RMIT

Show me
Three vaccine trials on Marek's disease
The findings from three trials conducted to assess the efficacy of the newly developed RMIT vaccine against Marek's disease are detailed in the report on this project.
This site requires you to update your browser. Your browsing experience may be affected by not having the most up to date version.
Please visit browser-update.org to upgrade.
JavaScript has been disabled in your browser. Please enable JavaScript to experience the full functionality of our website.

The findings from three trials conducted to assess the efficacy of the newly developed RMIT vaccine against Marek's disease are detailed in the report on this project.